Here are relevant reports on : sleep-disorders-therapeutics-market
-
Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Global Forecast to 2028
The global microbiome diagnostics market, valued at US$126 million in 2022, stood at US$146 million in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$300 million by the end of the period. Market growth is driven by the rising incidence of chronic diseases, collaborative efforts between microbiome industry and academic institutes, and growing demand of personalized medicine.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023
The transdermal drug delivery system market is projected to reach USD 7.1 billion by 2023, growing at a CAGR of 4.5%. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application (Personalized Storage, Clinical (Autoimmune, Hematopoietic Disorders), Research) - Global Forecasts to 2023
The global stem cell banking market is projected to reach USD 9.30 Billion by 2023, at a CAGR of 8.2%. Major players in the global stem cell banking market include Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Vascular Imaging Market by Technology (MRI, Ultrasound, CT, Hybrid, OCT), Application (Atherosclerosis, DVT, Vasculitis, Aneurysmal Disorders, AV Malformations, Tumours, Others), End User (Hospitals, Diagnostic Imaging Centers) - Global Forecast to 2030
The global vascular imaging market, valued at US$3.03 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2030, culminating in a forecasted valuation of US$4.67 billion by the end of the period. The growth of the vascular imaging market is driven by the rising prevalence of cardiovascular diseases, including atherosclerosis, peripheral artery disease, and stroke, which demand early diagnosis and monitoring.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Pressure Monitoring Market by Product (Oximeters, BP Cuffs, BP Monitors (Digital, Aneroid, Cuffless)), Procedure (Invasive & Non-invasive), Therapeutic Application (Respiratory and Cardiac Disorders, Glaucoma), End User - Global Forecast to 2032
The global pressure monitoring market, valued at US$13.63 billion in 2024, stood at US$14.56 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2032, culminating in a forecasted valuation of US$ 25.48 billion by the end of the period. The pressure monitoring market is experiencing significant growth driven by medical, technological, and demographic factors.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
US Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostic {PSG, Home Sleep Testing, Oximeter}], Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings] – Forecast to 2031
The US sleep apnea devices market, valued at US$2.90 billion in 2025, stood at US$3.11 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$4.54 billion by the end of the period. The market's growth can be attributed to the rising prevalence of sleep apnea and other lifestyle-related disorders. Additionally, greater awareness of the health risks associated with sleep apnea is expected to further boost demand for these devices.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Europe Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostics {PSG, Home Sleep Testing, Oximeter}]; Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings] - Forecast to 2031
The Europe Sleep Apnea Devices market, valued at US$1.76 billion in 2025, stood at US$1.88 billion in 2026 and is projected to advance at a resilient CAGR of 7.4% from 2026 to 2031, culminating in a forecasted valuation of US$2.79 billion by the end of the period. Market growth across Europe is driven primarily by the rising prevalence of obstructive sleep apnea and other chronic conditions, such as obesity and CVD.
- Published: May 2026
- Price: $ 8150
- TOC Available:
-
Sleep Apnea Devices Market by Product (Therapeutic (PAP (CPAP, APAP, BPAP), Oral Appliances, Masks), Diagnostic (PSG, Home Sleep Testing, Oximeter)), Age, Gender, End User (Sleep Clinics, Hospitals, Home Care Settings) - Global Forecast to 2032
The global sleep apnea devices market, valued at USD 6.47 billion in 2024, stood at USD 6.93 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2032, culminating in a forecasted valuation of USD 11.61 billion by the end of the period. The growth in this market is expected to be driven by a large pool of undiagnosed sleep apnea patients globally, as well as favorable reimbursement and financial aid for sleep apnea devices and therapies.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast to 2020
The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020. Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the medical automation market. However, high cost of automation is one of the key restraints for this market.
- Published: February 2016
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
